Qlaira Description

The active substances are estradiol valerate, or estradiol valerate combined with dienogest.
Each wallet (28 film-coated tablets) of Qlaira contains 26 active tablets in 4 different colours in rows 1, 2, 3 and 4, as well as 2 white inactive tablets in row 4.
Composition of the coloured tablets containing one or two active substances: 2 dark yellow tablets each containing 3 mg estradiol valerate.
5 medium red tablets each containing 2 mg estradiol valerate and 2 mg dienogest.
17 light yellow tablets each containing 2 mg estradiol valerate and 3 mg dienogest.
2 dark red tablets each containing 1 mg estradiol valerate.
Composition of the white inactive tablets: These tablets do not contain any active substances.
Excipients/Inactive Ingredients: Other ingredients in the coloured active tablets are: Tablet core: lactose monohydrate, maize starch, pregelatinised maize starch, povidone K25 (E1201), magnesium stearate (E572).
Tablet film-coating: hypromellose type 2910 (E464), macrogol 6000, talc (E553b), titanium dioxide (E171), iron oxide yellow (E172) and/or iron oxide red (E172).
Other ingredients in the white inactive tablets are: Tablet core: lactose monohydrate, maize starch, povidone K25 (E1201), magnesium stearate (E572).
Tablet film-coating: hypromellose type 2910 (E464), talc (E553b), titanium dioxide (E171).